{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1383670318922756483.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"James P. Edwards"}],"foaf:familyName":[{"@value":"Edwards"}],"foaf:givenName":[{"@value":"James P."}]}],"career":[{"institution":{"notation":[{"@value":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C., 3210 Merryfield Row, San Diego, California 92121"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1363670318922756480","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1021/jm701575k"},{"@type":"URI","@value":"https://pubs.acs.org/doi/pdf/10.1021/jm701575k"}],"notation":[{"@value":"Identification of a Potent, Selective, and Orally Active Leukotriene A<sub>4</sub> Hydrolase Inhibitor with Anti-Inflammatory Activity"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1021/jm701575k_YU7YTWwblytYrgBumnM4GHCpcRS"}]}